Skip to main content
BMEA logo

BMEA · Biomea Fusion, Inc. · Investor Relations

Track BMEA — free
$0.60 +0.02 (+2.58%) At close · Oct 23
Market Cap
$43.50M
Shares
72.48M
Volume · Oct 23 958.01K Avg daily vol (3M) 2.05M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-14 00:00 UTC Obesity Week 2026 Event

Past events

Date Event Type
2026-10-13 Biomea Fusion BMF-650 (GLP-131) Phase I Topline Results Conference Call Earnings call
2026-10-10 T1D Breakthrough Conference Conference
2026-09-29 EASD 2026 Event
2026-09-15 H.C. Wainwright 28th Annual Global Investment Conference Conference
2026-09-10 Citi's 2026 Biopharma Back to School Conference Conference
2026-06-11 Expert Webinar: The Latest Therapeutic Developments for Type 1 Diabetes Post-ADA Webcast
2026-06-10 Virtual Annual Meeting of Stockholders Shareholder meeting
2026-06-07 Menin Inhibitor Icovamenib Activates Mechanisms That Support Metabolic Health Event
2026-06-07 Icovamenib, a Menin Inhibitor, Improves Endogenous Insulin Secretion in Type 1 Diabetes: Results from the COVALENT-112 Study Event
2026-06-07 Glycemic Improvements with Icovamenib in T2D on Background GLP-1 Therapy: COVALENT-111 Subgroup Analysis Event
2026-06-04 2026 Jefferies Global Healthcare Conference Conference
2026-05-19 H.C. Wainwright 4th Annual BioConnect Investor Conference Conference
2026-05-05 Rodman & Renshaw fireside chat with Key Opinion Leader Alex Abitbol, M.D. Webcast
2026-04-28 COVALENT-112: 52-Week Icovamenib Data in Type 1 Diabetes Conference Call Conference
2026-03-30 Rodman & Renshaw Fireside Chat With Management of Biomea Fusion Webcast
2026-03-30 JP Morgan: Addressing Top-10 Questions With Biomea Fusion Management In 30 Minutes Event
2026-03-24 BMO Metabolic Health Summit Event
2026-03-14 19th International Conference on Advanced Technologies & Treatments for Diabetes “ATTD” Conference
2026-03-10 The Citizens Life Sciences Conference Conference
2026-02-26 Oppenheimer 36th Annual Healthcare Life Sciences Conference Conference
2026-01-15 44th Annual J.P. Morgan Healthcare Conference Conference
2025-12-09 Dr. Ralph DeFronzo clinical insights from the COVALENT-111 study Event
2025-12-06 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) Presentation #0062 Presentation
2025-12-05 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) Presentation #0062 Presentation
2025-12-03 8th Annual Evercore Healthcare Conference Conference

Source: https://investors.biomeafusion.com/

Key facts CIK 1840439 CUSIP 09077A106 13F (30d) 7 filings 7 filers Visit website Investor relations